
    
      This is a single center, dose escalation study of a single bolus dose of dexmedetomidine
      followed by a continuous infusion for up to 24 hours in neonates who are immediately post-op
      from cardiac surgery, and require tracheal intubation with mechanical ventilation in the
      post-op period.

      Pediatric populations may benefit from the favorable pharmacodynamic effects of this
      medication.
    
  